Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genia |
RCV000855432 | SCV000994985 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2L | 2019-10-03 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001784470 | SCV002016426 | pathogenic | not provided | 2019-10-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001858524 | SCV002116738 | pathogenic | Gnathodiaphyseal dysplasia; Autosomal recessive limb-girdle muscular dystrophy type 2L | 2024-07-23 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr453*) in the ANO5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ANO5 are known to be pathogenic (PMID: 21186264, 23606453, 25891276, 30919934). This variant is present in population databases (rs754889480, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with autosomal recessive myopathy (PMID: 31353849). ClinVar contains an entry for this variant (Variation ID: 694040). For these reasons, this variant has been classified as Pathogenic. |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV003985437 | SCV003806861 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2L; Miyoshi muscular dystrophy 3 | 2022-08-19 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1 very strong, PS4 strong, PM2 moderated, PM3 moderated |